Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab

Inflamm Bowel Dis. 2001 Nov;7(4):323-6. doi: 10.1097/00054725-200111000-00008.

Abstract

Cutaneous manifestations occur frequently in inflammatory bowel disease. The association between hidradenitis suppurativa (HS) and Crohn's disease (CD) has been reported. We present a new case supporting this association. A dramatic improvement after treatment with infliximab was achieved for both refractory fistulizing CD and axillary HS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Axilla
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Drug Eruptions / etiology*
  • Female
  • Gastrointestinal Agents / adverse effects*
  • Hidradenitis Suppurativa / complications
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Infliximab
  • Rectovaginal Fistula / complications
  • Rectovaginal Fistula / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab